OncClub: Join the Chat on Trending Trials in Cancer Complimentary print subscription for home or office delivery In-person and virtual events just for HCPs Lively expert panel discussions featuring peer-to-peer exchanges Subscribe to our eNewsletter for breaking news and curated content

OncClub: Join the Chat on Trending Trials in Cancer Complimentary print subscription for home or office delivery In-person and virtual events just for HCPs Lively expert panel discussions featuring peer-to-peer exchanges Subscribe to our eNewsletter for breaking news and curated content

View More Breast Cancer CAR T-cell Therapy Chronic Lymphocytic Leukemia Gastrointestinal Cancer Genitourinary Cancers Gynecologic Oncology Immuno-Oncology Lung Cancer Melanoma & Skin Cancer Multiple Myeloma Urothelial Cancer

Breast Cancer CAR T-cell Therapy Chronic Lymphocytic Leukemia Gastrointestinal Cancer Genitourinary Cancers Gynecologic Oncology Immuno-Oncology Lung Cancer Melanoma & Skin Cancer Multiple Myeloma Urothelial Cancer

All Oncology News

Pipeline Report

Rare Cancer Series

OncClub All Oncology News Pipeline Report Rare Cancer Series

Medical World News

OncLive News Network®

Thoracic Night Live

Insights Medical World News OncChats OncLive News Network®OncLive TV Peer Exchange Podcasts Rapid Readouts The Talk Thoracic Night Live

Conference Coverage

Conference Listing

Giants of Cancer Care

Scientific Interchanges

State of the Science Summit / IPC

Giants of Cancer Care PER Events Scientific Interchanges State of the Science Summit / IPC Webinars

Oncology Fellows

Supplements And Featured Publications

All Publications

Oncology Live Oncology Fellows Supplements And Featured Publications All Publications

Interactive Tools

Learning Modules

Interactive Tools Learning Modules Presentations Sponsored

Print Subscription

eNewsletter Print Subscription

Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

© 2022 MJH Life Sciences and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Spotlight

OncClub: Join the Chat on Trending Trials in Cancer
Complimentary print subscription for home or office delivery
In-person and virtual events just for HCPs
Lively expert panel discussions featuring peer-to-peer exchanges
Subscribe to our eNewsletter for breaking news and curated content

SpecialtySee All >

Breast Cancer
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gastrointestinal Cancer
Genitourinary Cancers
Gynecologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Multiple Myeloma
Urothelial Cancer

OncLive SOSS

Advertise
About OncLive
Editorial Board
CancerNetwork.com
CGTlive.com
CureToday.com
OncNursingNews.com
TargetedOnc.com
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information

2 Clarke Drive
Suite 100
Cranbury, NJ 08512

© 2022 MJH Life Sciences^™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.

Treatment Options for Relapsed/Refractory Diffuse Large B-Cell Lymphoma

EP. 1: Therapy Initiation Prior to Cytogenetic Testing Results

July 17th 2020

EP. 2: DLBCL Risk Assessment and Genetic Signatures

July 17th 2020

EP. 3: Newly Diagnosed DLBCL: Treatment Decision Factors

July 17th 2020

EP. 4: R/R DLBCL: Transplant Eligibility and R-CHOP

July 17th 2020

EP. 5: Relapsed/Refractory DLBCL Treatment Landscape

July 17th 2020

EP. 6: CAR T Cell Therapy in Relapsed/Refractory DLBCL

July 17th 2020

EP. 7: CAR T-Cell Therapy Response Rates

July 17th 2020

EP. 8: CAR T-Cell Therapy Clinical Trials

July 17th 2020

EP. 9: SADAL Trial Overview

July 17th 2020

EP. 10: SADAL Trial Regimen FDA Approval

July 17th 2020

<
1
2
>